Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva to market Alexza agitation treatment in the U.S.
Teva to market Alexza agitation treatment in the U.S.
Teva to market Alexza agitation treatment in the U.S.
Submitted by
admin
on May 8, 2013 - 10:44am
Source:
Reuters
News Tags:
Teva
Alexza
Adasuve
agitation
schizophrenia
bipolar disorder
Headline:
Teva to market Alexza agitation treatment in the U.S.
Do Not Allow Advertisers to Use My Personal information
